首页> 外文期刊>Nursing of intrgrated traditional Chinese and Western medicine(Zhong-Xiyi Jiehe Huli ) >自拟“蒲黄冰片膏”预防FOLFOX6方案化疗性静脉炎的临床观察
【24h】

自拟“蒲黄冰片膏”预防FOLFOX6方案化疗性静脉炎的临床观察

机译:自拟“蒲黄冰片膏”预防FOLFOX6方案化疗性静脉炎的临床观察

获取原文
       

摘要

Abstract:Objective To observe the clinical effect of Puhuang Bingpian plaster in prevention of phlebitis induced by chemotherapeutic drugs. Methods A total of 80 patients whose chemotherapy regimen was FOLFOX6 were randomly distributed into the prevention group and the control group, with 40 cases in each groups. Both two groups were given routine nursing care, and the prevention group was applied with external application of Puhuang Bingpian plaster additionally. During the chemotherapy treatment, the pain sensation, pain time and incidence of chemotherapeutic drugsinduced phlebitis were observed. Results The cumulative incidence of pain was 15.00% in prevention group and was 35.00% in the control group, with a significant difference (P<0.05). The median time of pain was (80.92±3.73) h in the prevention group and was (91.96±1.96) h in the control group, with a significant difference (P<0.05). The preventive group had a lower incidence of chemotherapeutic drugsinduced phlebitis compared with the control group (15.00% vs. 35.00%, P<0.05). Conclusion For patient with chemotherapy regimen of FOLFOX6, external application of Puhuang Bingpian plaster can effectively decrease the pain and chemotherapeutic phlebitis.
机译:摘要:目的观察蒲黄丙片膏预防化学治疗药物引起的静脉炎的临床效果。方法将80例化疗方案为FOLFOX6的患者随机分为预防组和对照组,每组40例。两组均进行常规护理,预防组外加蒲黄冰片膏药。化疗期间观察疼痛感觉,疼痛时间和化疗药物引起的静脉炎的发生率。结果预防组疼痛累积发生率为15.00%,对照组为35.00%,差异有统计学意义(P <0.05)。预防组的中位疼痛时间为(80.92±3.73)h,对照组为(91.96±1.96)h,差异有统计学意义(P <0.05)。预防组化疗药物引起的静脉炎的发生率比对照组低(15.00%vs. 35.00%,P <0.05)。结论对于FOLFOX6化疗方案的患者,外用蒲黄冰片膏药可有效减轻疼痛和化疗性静脉炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号